Nalaganje...
CAR T-cell therapy for lung cancer and malignant pleural mesothelioma
Immunotherapy is a promising field that harnesses the power of the immune system as a therapeutic agent for cancer treatment. Beneficial outcomes shown in patients with non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM) with relatively higher tumor-infiltrating T cells, comb...
Shranjeno v:
| izdano v: | Transl Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5581988/ https://ncbi.nlm.nih.gov/pubmed/28502785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2017.04.004 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|